Risdiplam Demonstrates Significant Motor Milestones in Infants with Type 1 SMA

In addition to increased motor milestone achievement, the safety profile of risdiplam was consistent with that observed in previous studies, with no new safety signals identified.

from Front page feed https://ift.tt/2zk9qSi